EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization

Aakanksha Harit iD, Michael Mor iD, Ron Yefet iD, Lee S Izhaki-Tavor iD, Meital Gal-Tanamy, Natalia T Freund, Moshe Dessau iD

Proceedings of the National Academy of Sciences · 31.03.2026 · 123 (13)

DOI: 10.1073/pnas.2523864123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 25.03.2026. Verfasst von Aakanksha Harit und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Lab for Structural Biology of Infectious Diseases, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, SARS-CoV-2, Antibodies, Monoclonal, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Israel Science Foundation (ISF), United States - Israel Binational Science Foundation (BSF), Bill and Melinda Gates Foundation (GF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic, which has resulted in over seven million global fatalities, poses a substantial threat to public health and precipitated a global economic crisis. Emerging variants of concern (VOCs) with enhanced transmissibility and improved immune evasion may compromise the efficacy of current antiviral and immunotherapies, necessitating comprehensive investigations into the immune response to SARS-CoV-2. The conformational dynamics of the receptor binding domain in SARS-CoV-2 spike and the presentation of neutralizing antibody epitopes influence viral transmission and infection rates. In this study, we have identified highly conserved non-receptor-binding motif epitopes for two potent monoclonal antibodies (mAbs), TAU-1109 and TAU-2310, isolated from convalescent human patients, which contribute to the broad neutralizing activity of these mAbs against all the circulating VOCs, including the recently emerged Omicron subvariants. We employed high-resolution structural data in conjunction with systematic biochemical investigation to elucidate the neutralization mechanism of TAU-1109 and TAU-2310. The mechanism involves antibody-mediated destabilization of the spike trimer, resulting in the premature shedding of the S1 subunit and rendering the spike incapable of mediating host cell entry. The identification of conserved cryptic epitopes in our study advances the mechanistic understanding of immune response against SARS-CoV-2, providing alternative avenues for the development of universal therapeutic antibodies and vaccines to combat COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingSARS-CoV-2Antibodies, MonoclonalSpike Glycoprotein, CoronavirusAntibodies, ViralEpitopesHumansCOVID-19Neutralization TestsConvalescenceModels, MolecularCrystallography, X-RayPandemics

Stichwörter der Autor:innen

SARS-CoV-2X-ray crystallographycross-neutralizationneutralizing antibodiesvirus–host cell interaction

Substanzen

Antibodies, NeutralizingAntibodies, MonoclonalSpike Glycoprotein, CoronavirusAntibodies, ViralEpitopesspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • The Lab for Structural Biology of Infectious Diseases, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.
  • Department of Clinical Microbiology and Immunology, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Molecular Virology Lab, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.

ORCID-Profile: Aakanksha Harit, Michael Mor, Ron Yefet, Lee S Izhaki-Tavor, Moshe Dessau

Förderung

  • Israel Science Foundation (ISF)
  • United States - Israel Binational Science Foundation (BSF)
  • Bill and Melinda Gates Foundation (GF)

Zitieren

APA

Harit, A., Mor, M., Yefet, R., Izhaki-Tavor, L. S., Gal-Tanamy, M., Freund, N. T., & Dessau, M. (2026). Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization. Proceedings of the National Academy of Sciences, 123(13). https://doi.org/10.1073/pnas.2523864123

Vancouver

Harit A, Mor M, Yefet R, Izhaki-Tavor LS, Gal-Tanamy M, Freund NT, et al. Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization. Proceedings of the National Academy of Sciences. 2026;123(13). doi:10.1073/pnas.2523864123

BibTeX
@article{Harit2026,
  author = {Harit, Aakanksha and Mor, Michael and Yefet, Ron and Izhaki-Tavor, Lee S and Gal-Tanamy, Meital and Freund, Natalia T and Dessau, Moshe},
  title = {Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {13},
  doi = {10.1073/pnas.2523864123}
}
Kostenlos starten →